Lv1
70 积分 2022-08-08 加入
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study
15天前
已完结
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
1个月前
已完结
Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer
1个月前
已完结
Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature
3个月前
已完结
mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study
6个月前
已关闭
Cancer survival statistics in China 2019-2021: a multicenter, population-based study
6个月前
已完结
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration
7个月前
已完结
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
7个月前
已完结
Comparison of hepatic arterial infusion chemotherapyversussorafenib monotherapy in patients with advanced hepatocellular carcinoma
9个月前
已完结
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
9个月前
已完结
皖公网安备34019202002308
